Description of Research Expertise

inflammatory bowel disease, Crohn's disease, ulcerative colitis, patient-reported outcomes, implementation science, clinical effectiveness, behavioral interventions, multiphase optimization strategy

Selected Publications

Tse CS, Hunt MG, Brown LA, Lewis JD.: Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions Inflamm Bowel Dis : 2023.

Tse CS, Nguyen HP, Singh S, Dulai PS, Neill J, Le H, Valasek M, Dervieux T, Collins AE, Boland BS.: Correlations Between Gastrointestinal Symptoms and Endoscopic-Histologic Disease Activity in Adults with Ulcerative Colitis Dig Dis Sci : 2023.

Tse CS, Weng CH, Kwon M, Wolk CB, Brown LA, Malani K, Shah SA, Fine SD.: Increased Risks for Suicide, Self-Harm, Substance Use, and Psychiatric Disorders in Adults With Inflammatory Bowel Disease: A Nationwide Study in the United States From 2007 to 2017 Inflamm Bowel Dis : 2023.

Tse CS, Melmed GY, Siegel CA, Weng CH, Shah SA, Weaver SA, Oliver BJ, Elwyn G, van Deen WK.: Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study Inflamm Bowel Dis 29 : 161-166,2023.

Tse CS, Singh S, Valasek MA, Neill J, Le H, Collins AE, Boland BS: Prevalence and Correlations of Gastrointestinal Symptoms With Endoscopic and Histologic Mucosal Healing in Crohn's Disease Am J Gastroenterol 118 : 748-751,2023.

de la Fuente J, Wang Y, Tan N, Kandlakunta H, Tse CS, Click RL.: Cardiac Masses (from a 15-Year Experience With 389 Surgical Cases) Am J Cardiol 185 : 100-106,2022.

Tse CS, Siegel CA, Weaver SA, Oliver BJ, Bresee C, van Deen WK, Melmed GY.: Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study Inflamm Bowel Dis 28 : 1565-1572,2022.

Kamp KJ, Hawes SE, Tse CS, Singh S, Dang N, Oberai R, Weaver SA, Melmed GY, Siegel CA, van Deen WK; IBD Qorus.: Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment Inflamm Bowel Dis : 2022.

Tse CS, Dulai PS: Dual Advanced Therapies and Novel Pharmacotherapies for Moderately to Severely Active Crohn’s Disease Gastroenterology Clinics of North America 51 (2): 283-98,2022.

Hill E, Nguyen NH, Qian AS, Patel S, Chen PL, Tse CS, Singh S: Impact of Comorbid Psychiatric Disorders on Healthcare Utilization in Patients with Inflammatory Bowel Disease: A Nationally Representative Cohort Study Dig Dis Sci : 07505-9,2022.

Academic Contact Information

3737 Market St, 11th Floor, Penn Digestive and Liver Health Center University City, Penn Medicine University City
Philadelphia, PA 19104
Phone: 215-380-6327
Patient appointments: 800-789-7366